QUOTE AND NEWS
GenEng News  Jun 23  Comment 
FDA approved Thermo Fisher Scientific’s Oncomine™ Dx Target Test as the first next-generation sequencing (NGS)-based companion diagnostic that screens tumor samples against panels of biomarkers to identify patients who may respond to one of...
GenEng News  May 18  Comment 
Agios’ Pharmaceuticals’ Phase III cancer candidate ivosidenib (AG-120) will have a next-generation sequencing (NGS) companion diagnostic (CDx) developed and commercialized by Thermo Fisher Scientific, under an agreement disclosed today by...
GenEng News  Jan 23  Comment 
Omicia said today it has acquired Spiral Genetics for an undisclosed price, in a deal designed to enhance the buyer’s Opal™ clinical genomics software platform with Spiral’s secondary next-generation sequencing (NGS) analysis and structural...
GenEng News  Jan 9  Comment 
10x Genomics entered into an agreement with PerkinElmer to advance next-generation sequencing (NGS) technology. The deal will combine the Chromium™ system from 10x Genomics with automation solutions from PerkinElmer. “Our collaboration...
GenEng News  Nov 11  Comment 
Royal Philips and the Westchester Medical Center Health Network launched WMCHealth’s new precision medicine initiative for personalized cancer treatment, which will use Philips’ IntelliSpace Genomics solution to integrate large-scale genomic...
GenEng News  Oct 25  Comment 
Menarini-Silicon Biosystems and Swift Biosciences announced a collaboration to offer customized next-generation sequencing (NGS) for oncology research and diagnostics. The first two products (marketed by Menarini-Silicon Biosystems) developed...





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki